Comprehensive asthma management comprises several key components of care, including: (1) the assessment and monitoring of current severity of asthma and the future risk for exacerbations; (2) partnership between the patient and the treatment team; (3) control of environmental factors and comorbid conditions; and (4) pharmacologic therapy.
Chronic pain affects approximately 100 million US adults, and has devastating consequences on quality of life (QoL) and functional status.
In the past several years, there have been significant changes in the management of asthma in the United States, beginning with the publication of the updated Guidelines for the Diagnosis and Management of Asthma in the Expert Panel Report 3 of the National Asthma Education and Prevention Program (NAEPP) in 2007.
Managed care organizations (MCOs) must play a pivotal role in the management of patients with chronic pain.
Asthma remains a significant public health issue, affecting approximately 25 million individuals in the United States alone. Despite the availability of evidence-based guidelines and newer, more effective therapies, adequate control of symptoms may be challenging, resulting in diminished quality of life, and in some cases, life-threatening exacerbations. Faculty Perspectives™ is a 4-part series addressing the latest issues in the care of patients with asthma. In this first issue, faculty experts discuss the prevalence, burden, epidemiology, and pathophysiology of the disease, the role of managed care pharmacy, and trends in management.
Page 2 of 2
Results 11 - 15 of 15
  • American Health & Drug Benefits
  • The Journal of Hematology Oncology Pharmacy
  • Lynx CME
  • The Oncology Pharmacist